• LAST PRICE
    42.8900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    17.2500/ 1
  • Ask / Lots
    68.1900/ 1
  • Open / Previous Close
    0.0000 / 42.8900
  • Day Range
    ---
  • 52 Week Range
    Low 27.9850
    High 50.9900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 43.96
TimeVolumeXENE
09:32 ET261743.705
09:34 ET87143.89
09:38 ET1610043.63
09:39 ET80043.63
09:43 ET20043.615
09:50 ET52743.41
09:52 ET67343.265
09:54 ET45043.27
09:57 ET30043.29
09:59 ET10043.42
10:01 ET55143.405
10:03 ET40043.415
10:06 ET467243.13
10:08 ET30043.095
10:10 ET280243.215
10:12 ET22343.2575
10:14 ET10043.17
10:17 ET40043.325
10:19 ET20043.325
10:21 ET30043.355
10:24 ET50043.405
10:26 ET1300043.33
10:28 ET1290043.495
10:30 ET50043.72
10:32 ET20043.7
10:33 ET150043.92
10:35 ET344343.46
10:48 ET20043.515
10:50 ET20043.535
10:53 ET130043.58
10:55 ET10043.65
10:57 ET107743.82
11:00 ET605243.965
11:02 ET10044.065
11:04 ET35144.07
11:06 ET20044.06
11:08 ET40044.06
11:09 ET140044.06
11:11 ET160044.16
11:13 ET30044.15
11:15 ET140044.37
11:18 ET201244.34
11:22 ET10044.33
11:24 ET100044.175
11:26 ET10044
11:27 ET10044.053
11:29 ET20044.07
11:36 ET10044.1
11:38 ET10044.1
11:40 ET279744.105
11:42 ET30044.13
11:44 ET20044.185
11:45 ET20044.27
11:47 ET134044.11
11:49 ET10044.09
11:51 ET70043.95
11:56 ET80043.76
11:58 ET10043.76
12:02 ET20043.77
12:05 ET10043.69
12:09 ET150043.83
12:14 ET30043.92
12:16 ET20043.98
12:20 ET20044.01
12:21 ET10043.99
12:23 ET68144.005
12:27 ET10043.99
12:30 ET240043.98
12:32 ET158843.925
12:38 ET40043.99
12:39 ET80043.99
12:41 ET112444.045
12:43 ET60043.995
12:45 ET10043.99
12:48 ET100043.91
12:54 ET110044
12:59 ET10043.99
01:01 ET20043.98
01:03 ET30043.97
01:06 ET60043.95
01:08 ET20043.98
01:10 ET150143.88
01:12 ET10043.9
01:17 ET70043.84
01:19 ET20043.84
01:21 ET30043.8925
01:24 ET20043.92
01:26 ET50443.94
01:28 ET20043.995
01:30 ET50044.02
01:32 ET70044.005
01:33 ET10044.005
01:35 ET60044.005
01:37 ET10044.005
01:39 ET95743.88
01:42 ET21443.88
01:44 ET10043.98
01:48 ET20043.99
01:50 ET23644.045
01:51 ET20044.05
01:53 ET30044.06
01:55 ET137744
01:57 ET10044.035
02:00 ET120043.97
02:02 ET110543.96
02:06 ET80043.88
02:08 ET60043.94
02:13 ET10043.95
02:15 ET112243.94
02:18 ET10043.96
02:20 ET20043.97
02:22 ET32343.98
02:24 ET20044.03
02:26 ET40044.04
02:27 ET124644.105
02:29 ET140443.94
02:31 ET48243.94
02:33 ET39443.94
02:38 ET30043.96
02:40 ET200043.9
02:42 ET60043.84
02:47 ET50043.775
02:49 ET126543.86
02:51 ET80043.74
02:54 ET50043.63
02:56 ET1730143.06
02:58 ET451843.1
03:00 ET140043.08
03:02 ET611143.22
03:03 ET35043.105
03:05 ET65043.16
03:07 ET115043.17
03:09 ET150043.425
03:12 ET20043.44
03:14 ET155043.31
03:20 ET10043.37
03:21 ET55243.34
03:23 ET518243.46
03:27 ET155243.44
03:30 ET20043.47
03:32 ET175043.15
03:34 ET144843.19
03:36 ET464543.125
03:38 ET90343.12
03:39 ET25043.15
03:41 ET320243.1
03:43 ET170043.025
03:45 ET105043.1
03:48 ET133043.08
03:50 ET474443.11
03:52 ET503142.88
03:54 ET397042.88
03:56 ET779142.96
03:57 ET262542.95
03:59 ET1941542.89
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXENE
Xenon Pharmaceuticals Inc
3.2B
-15.7x
---
United StatesIDYA
IDEAYA Biosciences Inc
3.2B
-22.1x
---
United StatesMLTX
MoonLake Immunotherapeutics
3.1B
-63.7x
---
United StatesVSBC
Vitaspring Biomedical Co. Ltd
3.1B
3,311.3x
---
United StatesIBRX
Immunitybio Inc
3.5B
-5.0x
---
United StatesCRNX
Crinetics Pharmaceuticals Inc
3.0B
-10.3x
---
As of 2024-03-19

Company Information

Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).

Contact Information

Headquarters
3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
Phone
604-484-3300
Fax
604-484-3450

Executives

Chairman of the Board
Simon Pimstone
President, Chief Executive Officer, Director
Ian Mortimer
Chief Financial Officer
Sherry Aulin
Executive Vice President - Drug Discovery
James Empfield
Executive Vice President - Strategy and Innovation
Robin Sherrington

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.2B
Revenue (TTM)
$0.00
Shares Outstanding
75.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.17
EPS
$-2.73
Book Value
$12.31
P/E Ratio
-15.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.